EDUCATION FOR A BETTER CHEMOTHERAPY EXPERIENCE€¦ · van Dulmen S, Driesenaar J, van Weert J, van...

Post on 30-Apr-2020

0 views 0 download

transcript

EDUCATION FOR A BETTER CHEMOTHERAPY EXPERIENCE

Ellen Manzullo, MD, FACP

Professor of Medicine Clinical Deputy Division Head, Internal Medicine

UT MD Anderson Cancer Center

Faculty Disclosure

No, nothing to disclose

SessionOutline

1.  AspectsofEduca0onpriortotheini0a0onofChemotherapy

2.  Thrombosisandeduca0ononit'spreven0onandtreatment

3.  Poten0alsideeffectsofChemotherapy

•  Ques0onsandAnswers

4.  PsychosocialaspectsoftreatmentwithChemotherapy

5.  HealthyLifestylePromo0on

•  Ques0onsandAnswers

ChallengesofPa2entEduca2onPriortoChemotherapy

•  Pa0entsoGenareoverwhelmedwithfacingapoten0allifethreateningillness

•  Many0mescancerpa0entsundergoextensivetreatmentoveraprolonged0mecourse

•  TheshiGinchemotherapytreatmentfromtheinpa0enttooutpa0entseKnghasdecreasedtheamountof0meforpa0enteduca0on

•  Outpa0entchemotherapyhasmadeitimportantforbothpa0entsaswellastheircaregiverstobeknowledgeableaboutsideeffecttreatmentinthehome

ChallengesofPa2entEduca2onPriortoChemotherapy

•  Morethan60%ofallcancerpa0entsare65yearsofageandabove

•  Many0mescancerpa0entsalsohaveamul0tudeofothercomorbidcondi0ons

•  Astudyhasshownthatolderpa0entsonlyac0velyrecalllessthanonefourthoftheeduca0onfocusedonsideeffecttreatmentprecedingchemotherapy

JansenJ,vanWJ,vanderMeulenN,vanDulmenS,HeerenT,BensingJ.(2008).Recallinoldercancerpa0ents:measuringmemoryformedical

informa0on.Gerontologist,48(2);149-157

Pa2entVOICE:AnOnlineCommunica2onToolforOlderPa2entswithCancer

•  Online,preparatorytoolwithaudiofocusedonimprovingthepar0cipa0onofolderpa0ents(65yearsorolder)duringeduca0onalnursingencountersbeforechemotherapyandalsoimprovingtheirinforma0onrecall

•  Pa0entVOICEwasdevelopedwithinvolvementofbothpa0entsandnurses

•  Pa0entVOICEprovidespre-visitinforma0onaboutchemotherapy,thenursingvisit,andtheroleofthepa0entduringtreatment

•  Futureresearchisgoingtobeconductedonit'su0lityandusabilityinagroupofolderpa0entswhoreceiveorhavereceivedchemotherapy

vanDulmenS,DriesenaarJ,vanWeertJ,vanOschM,NoordmanJ.(2017).Pa0entVOICE:DevelopmentofaPreparatory,Pre-ChemotherapyOnline

Communica0onToolforOlderPa0entsWithCancer.JMIRResearchProtocols,6(5),1-11

Evalua2onoftheAddi2onofVideo-basedEduca2onforPa2entsReceivingStandardPre-ChemotherapyEduca2on

•  Aimofthestudywastoevaluatetheusefulnessofaneduca0onalvideowithregardtopa0ents'abilitytorecallandreportsideeffectsoftreatment

•  Pa0entswerethosewithnewlydiagnosedbreastorcolorectalcancer,betweenages18-75,whoweretoreceiveadjuvantchemotherapy

•  Pa0entswererandomizedtoreceivestandardpre-chemotherapyeduca0onorstandardeduca0onplusaddi0onofavideo

•  Thevideo,"StayingWellDuringChemotherapy",focusedonmostcommonsideeffectsoftreatmentwitheduca0onontheirmanagement

Kinnane,N.,&Thompson,L.(2008).Evalua0onoftheaddi0onofvideo-basededuca0onforpa0entsreceivingstandardpre-chemotherapyeduca0on.

EuropeanJournalofCancerCare,17(4),328-339

Evalua2onoftheAddi2onofVideo-basedEduca2onforPa2entsReceivingStandardPre-ChemotherapyEduca2on

HypothesisoftheStudy:•  Pa0entswhowatchedthevideo

inaddi0ontoreceivingwriienandverbalinstruc0onsarebeierabletorecallsideeffectsoftreatmentandwouldperformearlyrepor0ngoftreatmentsideeffects

SpecificAimsoftheStudy:•  Comparerecallofinforma0on

regardingself-careandsideeffectsinpa0entswhowatchedthevideoaspartoftheirpre-chemotherapyeduca0onwiththosewhoreceivedstandardcare.

•  Surveypa0entsandevaluatetheusefulnessofthevideoinassis0ngthemmanagesideeffectsofchemotherapyinthehome.

Kinnane,N.,&Thompson,L.(2008).Evalua0onoftheaddi0onofvideo-basededuca0onforpa0entsreceivingstandardpre-chemotherapyeduca0on.

EuropeanJournalofCancerCare,17(4),328-339

Pa2entSelec2on

•  Pa0entswithcolorectalcancerandwerescheduledtoreceiveadjuvantchemotherapywithweekly5FluorouracilandFolinicAcid

•  Pa0entswithbreastcancerandwerereceiving5Fluorouracil,EpirubicinandCyclophosphamideorAdriamycin/EpirubicinandCyclophosphamideChemotherapy

•  Pa0entshadEnglishastheirprimarylanguage

•  ECOGscore0-2

Kinnane,N.,&Thompson,L.(2008).Evalua0onoftheaddi0onofvideo-basededuca0onforpa0entsreceivingstandardpre-chemotherapyeduca0on.

EuropeanJournalofCancerCare,17(4),328-339

ExclusionCriteria

•  Iftheyoranyimmediatefamilymemberhadpriorchemotherapy

•  Comorbidcondi0onthatwouldprohibitcomprehensionandgivinginformedconsent

•  Visuallyorhearingimpaired

•  Unabletocompletetheques0onnaire

Kinnane,N.,&Thompson,L.(2008).Evalua0onoftheaddi0onofvideo-basededuca0onforpa0entsreceivingstandardpre-chemotherapyeduca0on.

EuropeanJournalofCancerCare,17(4),328-339

WithdrawalCriteria

•  Pa0entswerewithdrawniftheyhadtoxici0esthatrequiredstoppingtreatment

•  Iftreatmenthadtobedeferredduetoseriousillnesslas0ngmorethan3weeks

Kinnane,N.,&Thompson,L.(2008).Evalua0onoftheaddi0onofvideo-basededuca0onforpa0entsreceivingstandardpre-chemotherapyeduca0on.

EuropeanJournalofCancerCare,17(4),328-339

"StayingWellDuringChemotherapy"includedthefollowing:

•  Selfhelpformul0plesymptoms–  Nausea/vomi0ng–  Infec0on–  Anemia–  Thrombocytopenia–  Mouthcare–  Dietary&fluidintake–  Diarrhea–  Cons0pa0on

•  Pa0entswerealsoinstructedwhentoseekmedicalcare

Kinnane,N.,&Thompson,L.(2008).Evalua0onoftheaddi0onofvideo-based

educa0onforpa0entsreceivingstandardpre-chemotherapyeduca0on.EuropeanJournalofCancerCare,17(4),328-339

"StayingWellDuringChemotherapy"includedthefollowing:

•  Pa0entscompletedabaselineques0onnaireevalua0ngknowledgeandanotherques0onnairepriortothesecondchemotherapycycleevalua0ngrecallofinforma0on

•  Pa0entswhowatchedthevideowereaskedtoassessthevideoaGer6cyclesofchemotherapy

•  Telephonecallstothedepartmentrepor0ngsymptomswereevaluatedforbothgroups

Kinnane,N.,&Thompson,L.(2008).Evalua0onoftheaddi0onofvideo-basededuca0onforpa0entsreceivingstandardpre-chemotherapyeduca0on.

EuropeanJournalofCancerCare,17(4),328-339

Results

•  Thevideogroupshowedatrendtowardshigherrecallininforma0onpertainingto:

–  Fever–  Mouthproblems–  Anemia–  Preven0onofcons0pa0on

•  Thevideogroupmorecommonlytelephonedrepor0ngmedicalproblemsof:

–  Nausea–  Vomi0ng–  Signsofinfec0oncomparewiththestandardgroup

InternetResourcesforPa2entsonChemotherapy:SideEffects

•  ASCO:hips://www.cancer.net/naviga0ng-cancer-care/side-effects

•  NCI:hips://www.cancer.gov/about-cancer/treatment/side-effects

•  ACS:hips://www.cancer.org/treatment/treatments-and-side-effects/physical-side-effects.html

Pa2ent-orientedAPPS

iOS(iPhone/iPad):

CaringBridgeHelpConnectcaregivers&Pa0entswithsupportsystem.Link:hips://itunes.apple.com/us/app/caringbridge/id365726944?mt=8

Cancer.netGuidesto120cancers,interac0vetooltokeeptrackofques0onstoaskprovidersandrecordvoiceanswers,symptomtrackerforsideeffects.Link:hips://itunes.apple.com/us/app/cancer-net-mobile/id433501257?mt=8

NCCNGuidelinesforPa2ents

VirtualPa0entversionofNCCNGuidelines.Havetobecomeuser(free).Link:hips://itunes.apple.com/us/app/nccn-pa0ent-guides-for-cancer/id1168594706?mt=8

CancerSurvivorshipConnec2onByGeorgiaCoreLinkstoSurvivorsVideos,Blogs,AppsandCancerhospitalsinGeorgiaLink:hips://itunes.apple.com/us/app/cancer-survivorship-connec0on/id1189987382?mt=8

Pa2ent-orientedAPPS

ANDROID:

SymptomManagementGuidelinesByCancerCareOntarioSimplifiedguides(includesFa0gue)Link:hips://play.google.com/store/apps/details?id=com.cancercare.symptommanagement

Cancer.netGuidesto120cancers,interac0vetooltokeeptrackofques0onstoaskprovidersandrecordvoiceanswers,symptomtrackerforsideeffects.Link:hips://play.google.com/store/apps/details?id=com.fueled.cancernet

NCCNGuidelinesforPa2entsVirtualPa0entversionofNCCNGuidelines.Havetobecomeuser(free).Link:hips://play.google.com/store/apps/details?id=com.mediaparts.nccn

ThrombosisandCancer

•  Riskofvenousthromboembolism(DVTorPE)isincreasedinpa0entsreceivingcancerchemotherapy.

•  Inthegeneralpopula0on,VTEoccursatarateof1per1000persons/yearor0.1%(2/3DVT,1/3PE)andpa0entswithcancerhaveanincidenceofreportedthrombo0ceventsthatrangesfrom4%to20%

•  VTEispresentatautopsyinapproximately50%ofpa0entswithcancer•  Cancerpa0entshavearecurrencerateofthrombo0cevents30mesthatof

generalpopula0on•  Riskofvenousthromboembolismalsorisesprogressivelyoverthecourseof

treatment•  Retrospec0vestudieshavesuggestedanassocia0onbetweencancer-

associatedvenousthromboembolismandpa0entsurvival

KudererN,CulakovaE,LymanG,FrancisC,FalangaA,KhoranaA.(2016).AValidatedRiskScoreforVenousThromboembolismIsPredic0veof

CancerProgressionandMortality.TheOncologist,21;861-867

ThrombosisandCancer

•  Venousthromboembolismisthesecondleadingcauseofdeathfollowingcancerprogression

•  Mayresultindelayordiscon0nua0onofchemotherapy•  Thrombosisincancerpa0entshasanincreasedriskofrecurrent

eventsaswellasmajorbleedingincomparisontothrombosisinnon-cancerpa0ents

KudererN,CulakovaE,LymanG,FrancisC,FalangaA,KhoranaA.(2016).AValidatedRiskScoreforVenousThromboembolismIsPredic0veof

CancerProgressionandMortality.TheOncologist,21;861-867

ClinicalRiskScore

Factor RiskScoreSiteofcancer

Veryhighrisk(stomach,pancreas)Highrisk(lung,lymphoma,gynecologic,bladder,tes0cular)

21

Prechemotherapyplateletcount≥350,000/mm3 1

Prechemotherapyleukocytecount>11,000/mm31

Hemoglobinlevel<10g/dLoruseofredcellgrowthfactors1

Bodymassindex≥35kg/m21

KudererN,CulakovaE,LymanG,FrancisC,FalangaA,KhoranaA.(2016).AValidatedRiskScoreforVenousThromboembolismIsPredic0veof

CancerProgressionandMortality.TheOncologist,21;861-867

Cumula0vescore:highrisk,≥3;intermediaterisk,1-2;lowrisk,0.

ThrombosisandCancer

•  Alarge,na0onwide,prospec0vecohortstudyofadultswithsolidtumorsorlymphomaini0a0ngchemotherapyfrom2002to2006at115USprac0cesiteswasperformed.

•  Purposeofthestudywastoinves0gateiftheVTEClinicalRiskScorealsopredictedearlymortalityandcancerprogression

•  Duringthefirst4monthsoftherapyof4,405pa0ents,134(30%)diedand330(7.5%)experienceddiseaseprogression

KudererN,CulakovaE,LymanG,FrancisC,FalangaA,KhoranaA.(2016).AValidatedRiskScoreforVenousThromboembolismIsPredic0veof

CancerProgressionandMortality.TheOncologist,21;861-867

Results

•  HighRiskPa0ents(n=540,12.3%)bytheClinicalRiskScorehada120daymortalityrateof12.7%

•  IntermediateRiskPa0ents(n=2,665,60.5%)hadamortalityrateof5.9%

•  LowRiskPa0ents(n=1,200,27.2%)hadamortalityrateof1.4%

120dayFollow-upResults:Cancerprogressionoccurredin27.2%ofhighriskpa0ents,16.4%ofintermediateriskpa0ents,and8.5%oflowriskpa0ents.

KudererN,CulakovaE,LymanG,FrancisC,FalangaA,KhoranaA.(2016).AValidatedRiskScoreforVenousThromboembolismIsPredic0veof

CancerProgressionandMortality.TheOncologist,21;861-867

Conclusion

•  VTEClinicalRiskScorewasalsopredic0veofearlymortalityandcancerprogressionduringthefirstfourcyclesofoutpa0entchemotherapy.Thiswasalsoindependentofothermajorprognos0cfactorsincludingVTE.

KudererN,CulakovaE,LymanG,FrancisC,FalangaA,KhoranaA.(2016).AValidatedRiskScoreforVenousThromboembolismIsPredic0veof

CancerProgressionandMortality.TheOncologist,21;861-867

Pa2entEduca2ononThrombosis

•  AmericanCollegeofPhysiciansPa0entEduca0onBookleton:WhatYouShouldKnowAboutBloodClots

“ADVTisabloodclotthatformsinthedeepveinsofyourbody,usuallyinthelegorarm.Iftheclotbreaksfreeandmovestothelungs,itcanblockbloodsupplyandmakeithardforoxygentogettotherestofyourbody.

ThisiscalledaPE.”

Pa2entEduca2ononThrombosis

•  RiskFactorsYouCannotChange–  Havingafamilyhistoryofbloodclots(bloodrela0vewhohashad

bloodclotsinthepastorabloodcloKngdisorder)–  Beingover60yearsofage–  Apersonalhistoryofbloodclots

•  RiskFactorsYouCanWorktoChange–  Smoking–  Beingoverweightorhavingobesity

•  Mul0pleRiskFactorsthatYouMayHaveDuringYourLife0me–  Cancerdiagnosis

WhatYouShouldKnowAboutBloodClots:RiskFactors,Preven0on,andTreatment.(2016).AmericanCollegeofPhysicians,1-24

Pa2entEduca2ononThrombosis

•  SymptomsofDVTandPE

•  Ac0onstotakeifhavingsymptomsofaDVTorPE

•  Waystopreventbloodclotsfromforming–  Importanceofregularexercise–  Smokingcessa0on–  Compressionstockings(Howtoapplyandtakeoff)

WarfinandOtherBloodThinners

WhatYouShouldKnowAboutBloodClots:RiskFactors,Preven0on,andTreatment.(2016).AmericanCollegeofPhysicians,1-24

Warfarin(Coumadin®) OtherBloodThinnersApixaban(Eliquis®),Dabigatran(Pradaxa®),Edoxaban(Savaysa®),Rivaroxaban(Xarelto®)

FoodInterac0ons

VitaminK—foundinleafygreenvegetables.Importanttoeatthesameamountandtypeeachweek.

Noknowninterac0onswithfood.

DrugInterac0ons

Over-thecounter:Herbalanddietarysupplements(ginger,ginsengandgarlic);an0-inflammatory(ibuprofenandnaproxen;coldmedicines).Prescrip2on:An0neoplas0c(cancer),heart,an0fungal,steroids,an0bio0cs,andan0depressantmedicines.

Talktoyourhealthcareprofessionalaboutpossibleinterac0onswithcurrentmedicines.Otherbloodthinnerscanhaveseveresideeffectsifnotmonitoredcorrectly.

BloodTests RequiresregularbloodtestscalledINRstomakesureyouareontherightdoseandthatyourbloodisnottoothickorthin.

Occasionalbloodteststomakesureyourblood,liver,andkidneysareworkingnormally.

Costs Lowercost(dependingonyourinsurancebenefits).

Highercost(dependingonyourinsurancebenefits).

PossibleSideEffects

Bleedingandbruising(talktoyourhealthcareprofessionalaboutyourriskforbleeding).

Bleedingandbruising(talktoyourhealthcareprofessionalaboutyourriskforbleeding).Possiblestomachdiscomfort.

Storage Canbestoredinapillorganizer. Dabigatranneedstobekeptinitsboile.Allotherscanbestoredinapillorganizer.

Prescrip2onMedica2ons

WhatYouShouldKnowAboutBloodClots:RiskFactors,Preven0on,andTreatment.(2016).AmericanCollegeofPhysicians,1-24

NameofMedicine Dosage Size,Shape

&ColorHowMuch

WhentoTake/HowtoUse

WhatIUseItFor

Start/StopDate Notes

Example:Warfarin 5mg small,oval,

peachcolor 1pill Takebymouth,everymorning BloodThinner 4/1/13-

Don'tskipdoses,beconsistentwithgreenveggies

Conclusion

•  Acancerdiagnosisisateachablemoment

•  Pa0enteduca0onpriortochemotherapyisessen0alandshouldfocusonpreven0onandtreatmentofsideeffectsaswellasinstruc0ononwhentoseekmedicalcare

•  Pa0entsshouldbeeducatedonthepossibilityofvenousthromboembolism(DVTorPE)andwaystopossiblypreventthisfromoccurringandthatitisamedicalemergency

•  Educa0onhelpspa0entsandtheircaregiversbebeieradvocatesfortheirwellbeing